OrbiMed Capital GP VII LLC insider trades: Electra Therapeutics (ETRA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where OrbiMed Capital GP VII LLC reports to the SEC
and 15 more companies
Open-market buys and sales
68 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | ETRA | ↑ Buy | 472,571 | $7.63 | $3.6M | Indirect | Nov 5, 2026 (0d) |
| Nov 2, 2026 | ASPE | ↑ Buy | 1,000,000 | $15.00 | $15.0M | Indirect | Nov 4, 2026 (2d) |
| Sep 28, 2026 | ADRX | ↑ Buy | 950,000 | $17.00 | $16.1M | Indirect | Sep 30, 2026 (2d) |
| Sep 21, 2026 | ETRA | ↑ Buy | 1,333,333 | $15.00 | $20.0M | Indirect | Sep 23, 2026 (2d) |
| Jun 22, 2026 | ELVN | ↓ Sell | 860,123 | $45.36 | $39.0M | Indirect | Jun 24, 2026 (2d) |
| Jun 15, 2026 | ELVN | ↓ Sell | 281,408 | $45.02 | $12.7M | Indirect | Jun 17, 2026 (2d) |
| May 28, 2026 | QTTB | ↑ Buy | 1,875,000 | $8.00 | $15.0M | Indirect | Jun 1, 2026 (4d) |
| Jun 26, 2025 | PASG | ↓ Sell | 583,657 | $0.34 | $197K | Indirect | Jun 26, 2025 (0d) |
| Apr 24, 2025 | PASG | ↓ Sell | 235,572 | $0.33 | $79K | Indirect | Apr 24, 2025 (0d) |
| Apr 17, 2025 | PASG | ↓ Sell | 149,054 | $0.33 | $50K | Indirect | Apr 17, 2025 (0d) |
| Feb 18, 2025 | MBX | ↑ Buy | 190,672 | $10.60 | $2.0M | Indirect | Feb 19, 2025 (1d) |
| Jan 14, 2025 | PASG | ↓ Sell | 223,219 | $0.64 | $142K | Indirect | Jan 14, 2025 (0d) |
| Jan 8, 2025 | PASG | ↓ Sell | 147,024 | $0.70 | $103K | Indirect | Jan 8, 2025 (0d) |
| Dec 20, 2024 | PASG | ↓ Sell | 230,321 | $0.60 | $138K | Indirect | Dec 26, 2024 (6d) |
| Dec 11, 2024 | PASG | ↓ Sell | 62,276 | $0.83 | $52K | Indirect | Dec 11, 2024 (0d) |
| Dec 6, 2024 | PASG | ↓ Sell | 97,103 | $0.80 | $77K | Indirect | Dec 6, 2024 (0d) |
| Sep 19, 2024 | PASG | ↓ Sell | 39,300 | $0.71 | $28K | Indirect | Sep 23, 2024 (4d) |
| Sep 18, 2024 | PASG | ↓ Sell | 200,131 | $0.73 | $147K | Indirect | Sep 18, 2024 (0d) |
| Sep 16, 2024 | MBX | ↑ Buy | 500,000 | $16.00 | $8.0M | By OrbiMed Private Investments VII, LP | Sep 17, 2024 (1d) |
| Sep 16, 2024 | MBX | ↑ Buy | 250,000 | $16.00 | $4.0M | By OrbiMed Genesis Master Fund, L.P. | Sep 17, 2024 (1d) |
| Aug 13, 2024 | KROS | ↓ Sell | 250,000 | $44.01 | $11.0M | Indirect | Aug 15, 2024 (2d) |
| Jul 16, 2024 | TERN | ↓ Sell | 56,164 | $10.00 | $562K | Indirect | Jul 17, 2024 (1d) |
| May 16, 2024 | ELVN | ↓ Sell | 1,033,300 | $22.14 | $22.9M | Indirect | May 20, 2024 (4d) |
| Aug 15, 2023 | GLTO | ↓ Sell | 822,680 | $0.75 | $617K | Indirect | Aug 17, 2023 (2d) |
| Jul 31, 2023 | GLTO | ↓ Sell | 209,400 | $3.00 | $628K | Indirect | Aug 2, 2023 (2d) |
| Jul 25, 2023 | GLTO | ↓ Sell | 39,200 | $2.92 | $114K | Indirect | Jul 27, 2023 (2d) |
| Jul 17, 2023 | THRX | ↑ Buy | 479,932 | $3.05 | $1.5M | Indirect | Jul 19, 2023 (2d) |
| Jul 13, 2023 | GLTO | ↓ Sell | 194,700 | $2.40 | $467K | Indirect | Jul 17, 2023 (4d) |
| Jun 28, 2023 | PASG | ↑ Buy | 1,192,577 | $0.84 | $1.0M | Indirect | Jun 29, 2023 (1d) |
| May 5, 2023 | KNTE | ↑ Buy | 1,377,473 | $2.80 | $3.9M | Indirect | May 8, 2023 (3d) |
| May 2, 2023 | KNTE | ↑ Buy | 1,346,342 | $2.61 | $3.5M | Indirect | May 2, 2023 (0d) |
| Apr 17, 2023 | GLTO | ↓ Sell | 68,481 | $1.87 | $128K | Indirect | Apr 17, 2023 (0d) |
| Apr 12, 2023 | GLTO | ↓ Sell | 67,537 | $1.80 | $121K | Indirect | Apr 12, 2023 (0d) |
| Apr 6, 2023 | GLTO | ↓ Sell | 102,630 | $2.16 | $222K | Indirect | Apr 7, 2023 (1d) |
| Dec 23, 2022 | TERN | ↑ Buy | 137,931 | $7.25 | $1000K | Indirect | Dec 28, 2022 (5d) |
| Nov 7, 2022 | THRX | ↑ Buy | 192,000 | $5.21 | $1.0M | Indirect | Nov 9, 2022 (2d) |
| Sep 19, 2022 | THRD | ↑ Buy | 300,000 | $17.00 | $5.1M | Indirect | Sep 21, 2022 (2d) |
| Aug 16, 2022 | TERN | ↑ Buy | 3,690,000 | $2.42 | $8.9M | Indirect | Aug 18, 2022 (2d) |
| Jun 24, 2022 | ARQT | ↓ Sell | 341,971 | $21.31 | $7.3M | Indirect | Jun 28, 2022 (4d) |
| May 4, 2022 | PASG | ↑ Buy | 525,000 | $1.94 | $1.0M | Indirect | May 5, 2022 (1d) |
| Apr 8, 2022 | ARQT | ↓ Sell | 878,200 | $20.68 | $18.2M | Indirect | Apr 8, 2022 (0d) |
| Feb 15, 2022 | KNTE | ↑ Buy | 195,700 | $10.17 | $2.0M | Indirect | Feb 15, 2022 (0d) |
| Jan 21, 2022 | THRX | ↑ Buy | 158,417 | $9.97 | $1.6M | Indirect | Jan 21, 2022 (0d) |
| Jan 20, 2022 | PASG | ↑ Buy | 369,100 | $5.42 | $2.0M | Indirect | Jan 24, 2022 (4d) |
| Jan 19, 2022 | PASG | ↑ Buy | 168,300 | $5.38 | $905K | Indirect | Jan 20, 2022 (1d) |
| Jan 13, 2022 | PASG | ↑ Buy | 150,000 | $5.61 | $841K | Indirect | Jan 13, 2022 (0d) |
| Jan 13, 2022 | THRX | ↑ Buy | 44,717 | $9.90 | $443K | Indirect | Jan 13, 2022 (0d) |
| Dec 16, 2021 | JANX | ↓ Sell | 393,300 | $19.07 | $7.5M | Indirect | Dec 17, 2021 (1d) |
| Oct 12, 2021 | THRX | ↑ Buy | 562,500 | $16.00 | $9.0M | By OrbiMed Private Investments VII, LP | Oct 14, 2021 (2d) |
| Oct 12, 2021 | THRX | ↑ Buy | 62,500 | $16.00 | $1.0M | By OrbiMed Genesis Master Fund, L.P. | Oct 14, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ETRA insiders
Open-market trades in the last 12 months
About OrbiMed Capital GP VII LLC's insider trades
OrbiMed Capital GP VII LLC is a director at Electra Therapeutics (ETRA). Since Dec 11, 2018, it has reported 38 open-market purchases worth $267.9M and 30 sales worth $125.9M on SEC Form 4. In the last 12 months: 5 buys ($69.8M) and 2 sales ($51.7M).
5 sales (3% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Its filings also include conversions (18 filings), grants and awards (4 filings), shares returned to the company (3 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ETRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.